Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Larysa Sokolova"'
Publikováno v:
Wiadomości Lekarskie. 74:1844-1849
OBJECTIVE The aim: To identify admission variables associated with Functional Ambulation Classif i cation (FAC) 1 to 4 (unable to walk without assistance) at time of discharge (dFAC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b247e6f360aff5fec4bf3d8bfb83c9d5
https://doi.org/10.36740/wlek202108112
https://doi.org/10.36740/wlek202108112
Publikováno v:
Current Opinion in Neurology. 34:27-37
Purpose of review The European Stroke Organisation published a European Stroke Action Plan (SAP-E) for the years 2018-2030. The SAP-E addresses the entire chain of care from primary prevention through to life after stroke. Within this document digita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0db07df44af6cf0bd2923e903201baa3
https://doi.org/10.1097/wco.0000000000000891
https://doi.org/10.1097/wco.0000000000000891
Autor:
Nataliia Bobryk, Larysa Sokolova
Publikováno v:
EUREKA: Health Sciences. 6:45-51
The prevalence rate of multiple sclerosis (MS) in Volyn Region (101.0 per 100000) is the highest in Ukraine. To study MS risk factors in Volyn Region, special questionnaires were distributed among all MS patients residing in Volyn region. Results wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa096278c7dbbf487274412dc9d90082
https://doi.org/10.21303/2504-5679.2016.00243
https://doi.org/10.21303/2504-5679.2016.00243
Publikováno v:
International Journal of Otolaryngology
International Journal of Otolaryngology, Vol 2014 (2014)
International Journal of Otolaryngology, Vol 2014 (2014)
A multicenter clinical trial was performed to compare the efficacy and safety ofGinkgo bilobaextract EGb 761 and betahistine at recommended doses in patients with vertigo. One hundred and sixty patients (mean age 58 years) were randomly assigned to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc2cd24b9dd95d640498a8bcce84b197
http://europepmc.org/articles/PMC4099171
http://europepmc.org/articles/PMC4099171
Autor:
Larysa Sokolova, Peter Turcani, Radomír Taláb, Eva Havrdova, Panayiotis Panayiotou, Franz Fazekas, Tetiana Kobys, Gábor Jakab, Sergii Moskovko, Theodoros Kyriakides, Sámuel Komoly, Thomas Berger, Egon Kurča, Nataliya Voloshyná, Jörg Kraus, Karl Vass, Norbert Vella, Saša Šega Jazbec, Latchezar Traykov, Ovidiu Bajenaru, Ivan Milanov, Alenka Horvat Ledinek, Tanja Hojs Fabjan, L'ubomír Lisý, Tetyana Nehrych
Publikováno v:
Frontiers in Neurology
BASE-Bielefeld Academic Search Engine
BASE-Bielefeld Academic Search Engine
Multiple sclerosis (MS) is a neurological disorder characterized by inflammatory demyelination and neurodegeneration in the central nervous system. Until recently, disease-modifying treatment was based on agents requiring parenteral delivery, thus li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c864bbe29883d9e8afd0a01cc649208
https://pubmed.ncbi.nlm.nih.gov/23641231
https://pubmed.ncbi.nlm.nih.gov/23641231